| 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia D Khanna, JD Fitzgerald, PP Khanna, S Bae, MK Singh, T Neogi, ... Arthritis care & research 64 (10), 1431-1446, 2012 | 2601* | 2012 |
| 2015 gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative T Neogi, TLTA Jansen, N Dalbeth, J Fransen, HR Schumacher, ... Arthritis & rheumatology 67 (10), 2557-2568, 2015 | 1520 | 2015 |
| 2020 American College of Rheumatology guideline for the management of gout JD FitzGerald, N Dalbeth, T Mikuls, R Brignardello‐Petersen, G Guyatt, ... Arthritis & Rheumatology 72 (6), 879-895, 2020 | 1153 | 2020 |
| Mechanism of action of colchicine in the treatment of gout N Dalbeth, TJ Lauterio, HR Wolfe Clinical therapeutics 36 (10), 1465-1479, 2014 | 463 | 2014 |
| Effects of allopurinol on the progression of chronic kidney disease SV Badve, EM Pascoe, A Tiku, N Boudville, FG Brown, A Cass, P Clarke, ... New England Journal of Medicine 382 (26), 2504-2513, 2020 | 393 | 2020 |
| Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol LK Stamp, WJ Taylor, PB Jones, JL Dockerty, J Drake, C Frampton, ... Arthritis & Rheumatism 64 (8), 2529-2536, 2012 | 379 | 2012 |
| CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation N Dalbeth, R Gundle, RJO Davies, YC Lee, AJ McMichael, MFC Callan The Journal of Immunology 173 (10), 6418-6426, 2004 | 363 | 2004 |
| Gout (primer) N Dalbeth, HK Choi, LAB Joosten, PP Khanna, H Matsuo, F Perez-Ruiz, ... Nature Reviews: Disease Primers 5 (1), 2019 | 298* | 2019 |
| Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout. N Dalbeth, S Kumar, L Stamp, P Gow The Journal of Rheumatology 33 (8), 1646-1650, 2006 | 291 | 2006 |
| Cellular characterization of the gouty tophus: a quantitative analysis N Dalbeth, B Pool, GD Gamble, T Smith, KE Callon, FM McQueen, ... Arthritis & Rheumatism 62 (5), 1549-1556, 2010 | 286 | 2010 |
| An update on the genetics of hyperuricaemia and gout TJ Major, N Dalbeth, EA Stahl, TR Merriman Nature Reviews Rheumatology 14 (6), 341-353, 2018 | 280 | 2018 |
| nail disease in psoriatic arthritis—clinically important, potentially treatable and often overlooked L Williamson, N Dalbeth, JL Dockerty, BC Gee, R Weatherall, ... Rheumatology 43 (6), 790-794, 2004 | 274 | 2004 |
| Urate crystal deposition in asymptomatic hyperuricaemia and symptomatic gout: a dual energy CT study N Dalbeth, ME House, O Aati, P Tan, C Franklin, A Horne, GD Gamble, ... Annals of the rheumatic diseases 74 (5), 908-911, 2015 | 264 | 2015 |
| A review of uric acid, crystal deposition disease, and gout F Perez-Ruiz, N Dalbeth, T Bardin Advances in therapy 32, 31-41, 2015 | 263 | 2015 |
| A subset of natural killer cells is greatly expanded within inflamed joints N Dalbeth, MFC Callan Arthritis & Rheumatism: Official Journal of the American College of …, 2002 | 263 | 2002 |
| National prevalence of gout derived from administrative health data in Aotearoa New Zealand D Winnard, C Wright, WJ Taylor, G Jackson, L Te Karu, PJ Gow, B Arroll, ... Rheumatology 51 (5), 901-909, 2012 | 260 | 2012 |
| Mechanisms of inflammation in gout N Dalbeth, DO Haskard Rheumatology 44 (9), 1090-1096, 2005 | 260 | 2005 |
| Mechanisms of bone erosion in gout: a quantitative analysis using plain radiography and computed tomography N Dalbeth, B Clark, K Gregory, G Gamble, T Sheehan, A Doyle, ... Annals of the rheumatic diseases 68 (8), 1290-1295, 2009 | 256 | 2009 |
| The genetic basis of hyperuricaemia and gout TR Merriman, N Dalbeth Joint Bone Spine 78 (1), 35-40, 2011 | 224 | 2011 |
| Evaluation of the diet wide contribution to serum urate levels: meta-analysis of population based cohorts TJ Major, RK Topless, N Dalbeth, TR Merriman bmj 363, 2018 | 223 | 2018 |
